Emerson (NYSE: EMR) reports Q3 EPS of $0.51, 6 cents worse than estimates. Revenues were $5.1 billion vs. $5.34 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE